HopeStage
Back to all studies
CompletedNCT02579642

Low-Dose Ketamine With Propofol for ECT in Depression

About this titleRead the official source — NCT02579642
Medication studyAges 18–70Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

What did participation involve?

Depending on the group, the protocol specifies the study medication (ketamine) or a placebo (an inactive comparison treatment).

Listed locations
Edmonton and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2015
Recruitment status
Completed
Enrollment listed in the registry
48
Sponsor
University of Alberta
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 18 Years to 70 Years
Official registry ID
NCT02579642
Official title
Show the full official title

Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Edmonton

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Alberta, a university.

Did this study involve medication?

Yes. The study involved medication, including ketamine and Placebo.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies